Short Squeeze Stocks
Short % is open short shares divided by SEC shares outstanding. Days to cover is how many days of average volume it would take to buy those short shares back. Names here clear a liquidity floor so thin issues do not dominate the list.
FINRA settlement Oct 30, 2026 · 237 squeeze risk · 1,600 elevated · 36 new this settlement
| Ticker | Company | Short % ↓ | Days to cover | vs prior | Risk |
|---|---|---|---|---|---|
| FLNC | Fluence Energy | 72.8% | 7.07 | +3.91% | Squeeze risk |
| WOLFNew | Wolfspeed | 54.7% | 8.91 | +5.93% | Squeeze risk |
| FRNM | Freenome | 52.0% | 8.08 | +3.35% | Squeeze risk |
| ONDSNew | Ondas | 43.1% | 6.23 | -3.12% | Squeeze risk |
| HTZ | Hertz Global Holdings | 39.9% | 5.68 | -0.65% | Squeeze risk |
| CCCC | C4 Therapeutics | 37.9% | 15.1 | +9.03% | Squeeze risk |
| EOSENew | Eos Energy Enterprises | 37.7% | 5.46 | -1.48% | Squeeze risk |
| SERV | Serve Robotics | 36.7% | 10.1 | +1.96% | Squeeze risk |
| BETA | BETA Technologies | 35.8% | 9.06 | -7.83% | Squeeze risk |
| SHOE | Shoe Station Group | 35.0% | 12.8 | -3.66% | Squeeze risk |
| PCT | PureCycle Technologies | 34.5% | 10.7 | +6.15% | Squeeze risk |
| CAPR | Capricor Therapeutics | 32.3% | 7.38 | -5.52% | Squeeze risk |
| NNE | Nano Nuclear Energy | 32.0% | 10.1 | -0.24% | Squeeze risk |
| XRX | Xerox Holdings | 31.9% | 5.29 | +12.77% | Squeeze risk |
| OCGN | Ocugen | 31.8% | 16.4 | +0.48% | Squeeze risk |
| NTLA | Intellia Therapeutics | 31.7% | 11.1 | -0.17% | Squeeze risk |
| TRIP | TripAdvisor | 31.6% | 12.5 | -3.66% | Squeeze risk |
| JACK | Jack In The Box | 31.5% | 12.7 | -2.24% | Squeeze risk |
| QUBT | Quantum Computing | 30.5% | 11.8 | -1.34% | Squeeze risk |
| GRPN | Groupon | 30.2% | 14.3 | -2.06% | Squeeze risk |
| KSS | KOHLS | 29.7% | 7.64 | +3.04% | Squeeze risk |
| ABEO | Abeona Therapeutics | 29.5% | 21.7 | -1.95% | Squeeze risk |
| RUN | Sunrun | 29.5% | 8.68 | -0.88% | Squeeze risk |
| REPL | Replimune Group | 29.3% | 8.31 | +6.23% | Squeeze risk |
| PLAY | Dave & Buster's Entertainment | 29.3% | 5.58 | -4.04% | Squeeze risk |
| BBAI | BigBear.ai Holdings | 29.0% | 7.19 | +1.76% | Squeeze risk |
| RIG | Transocean | 28.9% | 6.65 | +3.18% | Squeeze risk |
| CSIQ | Canadian Solar | 28.6% | 11.4 | -0.17% | Squeeze risk |
| TNGX | Tango Therapeutics | 28.6% | 9.73 | +7.73% | Squeeze risk |
| NGNE | Neurogene | 28.4% | 17.0 | +11.63% | Squeeze risk |
| SLS | SELLAS Life Sciences Group | 28.3% | 6.70 | +6.26% | Squeeze risk |
| NVAXNew | Novavax | 28.1% | 7.61 | -2.15% | Squeeze risk |
| SRZNNew | Surrozen, Inc./DE | 27.5% | 8.51 | +3.31% | Squeeze risk |
| UPST | Upstart Holdings | 27.2% | 7.89 | -1.43% | Squeeze risk |
| SOC | Sable Offshore | 26.9% | 9.00 | -5.19% | Squeeze risk |
| ZENA | ZenaTech | 26.7% | 6.17 | -8.01% | Squeeze risk |
| BLLN | BillionToOne | 26.6% | 6.69 | +1.30% | Squeeze risk |
| RXRXNew | Recursion Pharmaceuticals | 26.6% | 6.10 | -12.14% | Squeeze risk |
| SPCE | Virgin Galactic Holdings | 26.5% | 7.57 | +2.85% | Squeeze risk |
| MVISNew | Microvision | 26.3% | 6.03 | -12.48% | Squeeze risk |
| RH | Rh | 26.0% | 5.99 | -9.68% | Squeeze risk |
| ARRY | Array Technologies | 25.9% | 5.48 | -7.24% | Squeeze risk |
| UAMY | United States Antimony | 25.8% | 6.44 | +3.23% | Squeeze risk |
| WEN | Wendy's | 25.8% | 5.90 | -5.70% | Squeeze risk |
| LCID | Lucid Group | 25.7% | 9.07 | +1.39% | Squeeze risk |
| TMDX | TransMedics Group | 25.6% | 10.2 | +1.24% | Squeeze risk |
| DDD | 3d Systems | 25.6% | 19.5 | -2.69% | Squeeze risk |
| RCAT | Red Cat Holdings | 25.5% | 6.32 | +3.47% | Squeeze risk |
| BTDR | Bitdeer Technologies Group | 25.4% | 5.95 | -0.49% | Squeeze risk |
| GRRRNew | Gorilla Technology Group | 25.4% | 5.45 | +11.23% | Squeeze risk |
| OXM | Oxford Industries | 25.3% | 7.32 | -4.93% | Squeeze risk |
| BEAM | Beam Therapeutics | 25.3% | 13.7 | -0.61% | Squeeze risk |
| EDIT | Editas Medicine | 25.2% | 17.6 | +1.40% | Squeeze risk |
| MCHB | Mechanics Bancorp | 25.2% | 6.52 | +19.61% | Squeeze risk |
| GLOB | Globant S.A. | 25.1% | 10.7 | +29.10% | Squeeze risk |
| MPT | Medical Properties Trust | 24.9% | 7.59 | -0.51% | Squeeze risk |
| GLUE | Monte Rosa Therapeutics | 24.5% | 15.7 | +0.95% | Squeeze risk |
| ASPI | ASP Isotopes | 24.1% | 7.80 | +8.00% | Squeeze risk |
| RARE | Ultragenyx Pharmaceutical | 24.0% | 8.27 | +17.27% | Squeeze risk |
| FLO | Flowers Foods | 23.9% | 9.70 | +9.32% | Squeeze risk |
| JBGS | JBG SMITH Properties | 23.8% | 18.9 | +0.94% | Squeeze risk |
| CHPT | ChargePoint Holdings | 23.8% | 7.91 | +3.48% | Squeeze risk |
| OPEN | Opendoor Technologies | 23.5% | 6.97 | +0.90% | Squeeze risk |
| AQST | Aquestive Therapeutics | 23.4% | 13.2 | +6.24% | Squeeze risk |
| TNDM | Tandem Diabetes Care | 23.2% | 7.63 | +7.19% | Squeeze risk |
| UUUU | Energy Fuels | 23.1% | 6.15 | -0.47% | Squeeze risk |
| INBX | Inhibrx Biosciences | 23.0% | 10.0 | -0.82% | Squeeze risk |
| LOVE | Lovesac | 22.9% | 16.7 | +3.26% | Squeeze risk |
| MNRO | Monro | 22.8% | 7.30 | -1.46% | Squeeze risk |
| CBRL | Cracker Barrel Old Country Store | 22.8% | 5.70 | -7.36% | Squeeze risk |
| CORZ | Core Scientific, Inc./tx | 22.7% | 5.04 | -4.73% | Squeeze risk |
| CMPX | Compass Therapeutics | 22.7% | 18.9 | -2.53% | Squeeze risk |
| CABA | Cabaletta Bio | 22.6% | 8.19 | -2.33% | Squeeze risk |
| LENZ | LENZ Therapeutics | 22.5% | 5.60 | -22.27% | Squeeze risk |
| VITL | Vital Farms | 22.4% | 6.05 | +8.11% | Squeeze risk |
| QBTS | D-Wave Quantum | 22.3% | 6.39 | +4.23% | Squeeze risk |
| BBW | Build-A-Bear Workshop | 22.0% | 6.59 | -3.76% | Squeeze risk |
| WGS | GeneDx Holdings | 22.0% | 7.27 | +8.83% | Squeeze risk |
| RNA | Atrium Therapeutics | 21.9% | 16.1 | +0.61% | Squeeze risk |
| DFDVNew | DeFi Development | 21.9% | 5.53 | +0.71% | Squeeze risk |
| VYX | NCR Voyix | 21.9% | 12.3 | -5.61% | Squeeze risk |
| VSTMNew | Verastem | 21.7% | 5.17 | +14.34% | Squeeze risk |
| ALT | Altimmune | 21.7% | 12.2 | -0.24% | Squeeze risk |
| YELP | Yelp | 21.5% | 10.1 | +2.05% | Squeeze risk |
| GMRSNew | GMR Solutions | 21.4% | 9.30 | +4.99% | Squeeze risk |
| HIVE | HIVE Digital Technologies | 21.3% | 5.07 | +1.70% | Squeeze risk |
| LYFT | Lyft | 21.3% | 9.05 | -1.01% | Squeeze risk |
| SNDX | Syndax Pharmaceuticals | 21.2% | 6.41 | +5.10% | Squeeze risk |
| PAR | Par Technology | 21.2% | 12.6 | -1.49% | Squeeze risk |
| CRVS | Corvus Pharmaceuticals | 21.1% | 18.9 | -1.16% | Squeeze risk |
| QDELNew | QuidelOrtho | 21.1% | 7.60 | +11.34% | Squeeze risk |
| CELC | Celcuity | 21.1% | 5.85 | +0.50% | Squeeze risk |
| WKC | World Kinect | 21.0% | 13.0 | -6.16% | Squeeze risk |
| CTXR | Citius Pharmaceuticals | 21.0% | 17.8 | +1.17% | Squeeze risk |
| BMEANew | Biomea Fusion | 21.0% | 8.44 | -3.19% | Squeeze risk |
| EQPTNew | EquipmentShare.com | 20.9% | 5.64 | -11.98% | Squeeze risk |
| ABSI | Absci | 20.9% | 9.06 | -3.18% | Squeeze risk |
| EYE | National Vision Holdings | 20.8% | 9.02 | +4.39% | Squeeze risk |
| CTMX | CytomX Therapeutics | 20.8% | 12.0 | +5.74% | Squeeze risk |
| LXEO | Lexeo Therapeutics | 20.8% | 12.7 | -2.94% | Squeeze risk |
How to read this. Squeeze risk: short % ≥ 15% and days to cover ≥ 5. Elevated: short % ≥ 7% or days to cover ≥ 5 (and not already squeeze risk). A New badge means the ticker was not squeeze-risk at the prior FINRA settlement. Average daily volume ≥ 100,000 and shares outstanding ≥ 1,000,000. Change vs prior is the FINRA change in shares short (positive = more short). No prices. Always free.
Data: FINRA, as of Oct 30, 2026. Short interest is a twice-monthly snapshot of open short positions reported by broker-dealers under FINRA Rule 4560. It is not a live figure. FINRA Equity Short Interest ↗ Shares outstanding from SEC XBRL (company filings). Not a recommendation.